Drugs

Question 1

Metformin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 1

A. Biguanides

Question 2

Alogliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 2

B. DPP-4 Inhibitors

Question 3

Sitagliptin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 3

B. DPP-4 Inhibitors

Question 4

Dulaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 4

C. GLP-1 Agonist

Question 5

Liraglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 5

C. GLP-1 Agonist

Question 6

Semaglutide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 6

C. GLP-1 Agonist

Question 7

Dapagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 7

E. SGLT-2 Inhibitor

Question 8

Empagliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 8

E. SGLT-2 Inhibitor

Question 9

Glipizide
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 9

F. Sufonylurea

Question 10

Pioglitazone
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sufonylurea
G. TZD

Answer 10

G. TZD

Question 11

Which of the following are agents that enhance insulin secretion?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 11

F. Sulfonylurea
G. Meglitinides

Question 12

Glyburide, Glipizide, and Glimepiride are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 12

F. Sulfonylurea

Question 13

Nateglinide and Repaglinide are examples of what medication group?
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 13

G. Meglitinides

Question 14

Agents that enhance _____ secretion include sulfonylureas with (short/prolonged) duration of action vs meglitinides with a (short/prolonged) duration of action.

Answer 14

Agents that enhance insulin secretion include sulfonylureas with prolonged duration of action vs meglitinides with a short duration of action.

Question 15

Agents that enhance the incretin effect
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 15

B. DPP-4 Inhibitors
C. GLP-1 Agonist

Question 16

Exenatide, Liraglutide, Lixenatide, Dulaglutide, and Semaglutide are examples of which group
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 16

C. GLP-1 Agonist

Question 17

Saxagliptin, Sitagliptin, Linagliptin and Alogliptin are examples of which class
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 17

B. DPP-4 Inhibitors

Question 18

Which are agents that reduce glucose absorption or increase glucose excretion
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 18

E. SGLT-2 Inhibitor

Question 19

Canagliflozin, Empagliflozin, Dapagliflozin, and Ertugliflozin
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 19

E. SGLT-2 Inhibitor

Question 20

Agents that reduce insulin resistance/lipotoxicity
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 20

A. Biguanides
H. TZD

Question 21

Metformin is an example of which drug group
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 21

A. Biguanides

Question 22

Pioglitazone and Rosiglitazone are examples of what class
A. Biguanides
B. DPP-4 Inhibitors
C. GLP-1 Agonist
D. Insulin
E. SGLT-2 Inhibitor
F. Sulfonylurea
G. Meglitinides
H. TZD

Answer 22

H. TZD

Question 23

Humulin-R U500 has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

Answer 23

D. 300 units

Question 24

Degludec U200 (Tresiba) has which maximum dose delivery
A. 60 units
B. 80 units
C. 160 units
D. 300 units

Answer 24

C. 160 units

Question 25

Degludec U300 (Toujeo) has which maximum dose delivery A. 60 units B. 80 units C. 160 units D. 300 units

Answer 25

B. 80 units

Question 26

Degludec U 300 (Toujeo Max) has which maximum dose delivery A. 60 units B. 80 units C. 160 units D. 300 units

Answer 26

C. 160 units

Question 27

Lispro U200 (Humalog Kwikpen) has which maximum dose delivery A. 60 units B. 80 units C. 160 units D. 300 units

Answer 27

A. 60 units

Question 28

Humulin-R U500 come in which unit increment A. 1 B. 2 C. 3 D. 4 E. 5

Answer 28

E. 5

Question 29

Degludec U200 (Tresiba) come in which unit increment A. 1 B. 2 C. 3 D. 4 E. 5

Answer 29

B. 2

Question 30

Glargine U300 (Toujeo) come in which unit increment A. 1 B. 2 C. 3 D. 4 E. 5

Answer 30

A. 1

Question 31

Glargine U 300 (Toujeo Max) come in which unit increment A. 1 B. 2 C. 3 D. 4 E. 5

Answer 31

B. 2